Phase 3 Prostate Cancer Trial, Recruiting (NCT07427043)

Phase 3 Prostate Cancer Trial, Recruiting NCT07427043 Sponsor: Brigham and Women's Hospital Condition: Prostate Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT07427043 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Prostate Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are a man aged 45 or older
You are scheduled to have a type of prostate removal surgery using a robotic-assisted technique at Brigham and Women's Hospital (BWH) or Brigham and Women's Faulkner Hospital (BWFH)
You are able to understand and sign a consent form agreeing to take part in the study

Who may not be able to join:

You have chronic kidney disease or your kidney function tests show levels above a certain threshold (confirm with trial site)
You have an allergy to, or a medical reason you cannot take, anti-inflammatory pain medicines such as ibuprofen or naproxen (known as NSAIDs)
You regularly use opioid pain medicines or have a history of substance misuse before your surgery
You are not able to give your own consent to take part in the study
Your surgery does not go as planned — for example, if a serious complication occurs during the operation that means your case is no longer considered routine

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 2 July 2026

Phase 3: approximately ~65% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.

Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07427043

Sponsor: Brigham and Women's Hospital

Phase: Phase 3

Status: Recruiting

Condition: Prostate Cancer

More information: https://clinicaltrials.gov/study/NCT07427043

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are a man aged 45 or older
You are scheduled to have a type of prostate removal surgery using a robotic-assisted technique at Brigham and Women's Hospital (BWH) or Brigham and Women's Faulkner Hospital (BWFH)
You are able to understand and sign a consent form agreeing to take part in the study

Who may not be able to join:

You have chronic kidney disease or your kidney function tests show levels above a certain threshold (confirm with trial site)
You have an allergy to, or a medical reason you cannot take, anti-inflammatory pain medicines such as ibuprofen or naproxen (known as NSAIDs)
You regularly use opioid pain medicines or have a history of substance misuse before your surgery
You are not able to give your own consent to take part in the study
Your surgery does not go as planned — for example, if a serious complication occurs during the operation that means your case is no longer considered routine

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 2 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Phase 3

Sponsor

Brigham and Women's Hospital

Registry

ClinicalTrials.gov

Start date

1 March 2026

Est. completion

31 December 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Post-discharge opioid consumption (MME)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 2 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov